Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
出版年份 2017 全文链接
标题
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 109, Issue 9, Pages -
出版商
Oxford University Press (OUP)
发表日期
2017-01-30
DOI
10.1093/jnci/djx015
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes—A 10-year Experience at a Single Center
- (2016) Waleed Shady et al. RADIOLOGY
- Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group
- (2015) Lieke H J Simkens et al. LANCET
- FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
- (2015) Chiara Cremolini et al. LANCET ONCOLOGY
- Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma
- (2014) Christina Hackl et al. BMC CANCER
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
- (2014) Volker Heinemann et al. LANCET ONCOLOGY
- Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update
- (2014) Muneeb Ahmed et al. RADIOLOGY
- Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
- (2013) Bernard Nordlinger et al. LANCET ONCOLOGY
- Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)
- (2012) T. Ruers et al. ANNALS OF ONCOLOGY
- Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer
- (2011) Leonard Saltz et al. Clinical Colorectal Cancer
- Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution
- (2010) Michael G. House et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours
- (2009) Laura Crocetti et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases
- (2009) Axel Stang et al. EUROPEAN JOURNAL OF CANCER
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology 2009 Clinical Evidence Review on Radiofrequency Ablation of Hepatic Metastases From Colorectal Cancer
- (2009) Sandra L. Wong et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
- (2009) Gunnar Folprecht et al. LANCET ONCOLOGY
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
- (2009) Jolien Tol et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started